Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             135 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2011
 43 S2 p. S109-S113
5 p.
 artikel
2 Editorial Board 2011
 43 S2 p. i-
1 p.
 artikel
3 F-10 Acute and chronic rejection during interferon therapy in HCV recurrent transplant patients: Results from the AISF-RECOLT-C group Rendina, M.
 2011
 43 S2 p. S95-
1 p.
 artikel
4 F-43 A multicenter prospective observational study to evaluate factors influencing efficacy, tolerance and compliance to antiviral tretament with interferon and ribavirin in daily clinical practice Di Marco, V.
 2011
 43 S2 p. S106-
1 p.
 artikel
5 F-20 An increased and activated Vd1 population characterises patients with active and advanced HCV-related liver disease Ferri, S.
 2011
 43 S2 p. S98-
1 p.
 artikel
6 F-49 A randomized multicentre double-blind vs placebo trial: Evaluation of effect of silybin conjugated with phosphatidilcholine and vitamin E on liver damage in patients with nonalcoholic fatty liver disease Andreone, P.
 2011
 43 S2 p. S108-
1 p.
 artikel
7 F-19 CD4+CD25hiFoxp3+ T-regs and liver transplantation for and-stage HCV-related liver disease: A role in HCV recurrence? Ferri, S.
 2011
 43 S2 p. S98-
1 p.
 artikel
8 F-26 Changes in tumor stiffness for early prediction of tumor response to sorafenib: a proof-of-concept study with elastosonography in an animal model of hepatocellular carcinoma (HCC) Salvatore, V.
 2011
 43 S2 p. S100-
1 p.
 artikel
9 F-3 Characterization, back-up and follow-up of occult hepatitis B infection (OBI) among blood donors Foglieni, B.
 2011
 43 S2 p. S93-
1 p.
 artikel
10 F-41 Chromatin dynamics of genes repression in response to IFNa reveal new roles for STAT2, phospho-STAT2, histone deacetylases (HDACs) and histone methylation marks Testoni, B.
 2011
 43 S2 p. S105-
1 p.
 artikel
11 F-38 Contrast-enhanced ultrasound and serological biomarkers for early evaluation of clinical outcome of HCC sorafenib treatment Olivani, A.
 2011
 43 S2 p. S104-
1 p.
 artikel
12 F-32 Cytoplasmic rings/rods autoantibodies; a novel serum antibody developing during peginterferon therapy in patients with chronic hepatits C Covini, G.
 2011
 43 S2 p. S102-
1 p.
 artikel
13 F-11 Detection of HCV natural recombinant 2k/1b in Asian people living in Italy: A challenge for diagnostic tools Longo, R.
 2011
 43 S2 p. S95-
1 p.
 artikel
14 F-17 Dietary iron overload induces visceral adipose tissue insulin resistance and hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance Dongiovanni, P.
 2011
 43 S2 p. S97-
1 p.
 artikel
15 F-45 Early liver steatosis during choline-deficient diet is associated with altered distribution of caveolin-1 (CAV1) within lipid droplets and mitochondria in steatotic rat hepatocytes Mastrodonato, M.
 2011
 43 S2 p. S106-S107
2 p.
 artikel
16 F-36 Effectiveness and safety of tenofovir disoproxil fumarate in field practice: A multicenter European cohort study of 737 patients with chronic hepatitis B Lampertico, P.
 2011
 43 S2 p. S103-S104
2 p.
 artikel
17 F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis Coppola, N.
 2011
 43 S2 p. S94-
1 p.
 artikel
18 F-14 Evidence of clonal evolution of tumor initiating cells in human hepatocellular carcinoma Colombo, F.
 2011
 43 S2 p. S96-
1 p.
 artikel
19 F-25 Garlic extract reduces rat liver fibrosis and collagen content via TGFβ and tissue transglutaminase inactivation Morisco, F.
 2011
 43 S2 p. S100-
1 p.
 artikel
20 F-18 Graft related gain in life expectancy according to MELD score in liver transplantation Vitale, A.
 2011
 43 S2 p. S97-S98
2 p.
 artikel
21 F-46 HBx-specific immune response in hepatitis B patients with different stage of disease Testa, L.
 2011
 43 S2 p. S107-
1 p.
 artikel
22 F-48 HCV relapses occur within 3 months after treatment in liver transplanted patients receiving pegylated IFN and ribavirin Visco-Comandini, U.
 2011
 43 S2 p. S107-
1 p.
 artikel
23 F-4 Hemodynamic response to beta-blockers for portal hypertension: A single center experience Tiani, C.
 2011
 43 S2 p. S93-
1 p.
 artikel
24 F-27 Hepatitis C virus modulates focal adhesion kinase promoting cytoskeletal reorganization in hepatocytes and a pro-fibrogenic phenotype in hepatic stellate cells Alisi, A.
 2011
 43 S2 p. S100-
1 p.
 artikel
25 F-5 Hepatocellular carcinoma (HCC) in cirrhosis: Long-term results of percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus Giorgio, A.
 2011
 43 S2 p. S93-S94
2 p.
 artikel
26 F-8 Hepatocellular carcinoma in cirrhosis extended in the main portal vein: A randomised controlled trial comparing percutaneous radiofrequency ablation of both hepatocellular carcinoma nodules and the portal venous tumor thrombus plus sorafenib with sorafenib alone Giorgio, A.
 2011
 43 S2 p. S94-S95
2 p.
 artikel
27 F-33 High prevalence of reduced bone mineral density in patients with chronic hepatitis B under nucleos(t)ides analogues treatment Viganò, M.
 2011
 43 S2 p. S102-
1 p.
 artikel
28 F-1 Identification of cancer stem cells in human hepatocellular and cholangiocellular carcinoma Lorenzini, S.
 2011
 43 S2 p. S92-
1 p.
 artikel
29 F-30 IL28B genotype distribution and treatment outcome among patients with chronic hepatitis C (CHC): Impact evaluation in a southern Europe population Madonia, S.
 2011
 43 S2 p. S101-
1 p.
 artikel
30 F-24 Immune response and gender disparity influence liver regeneration after acute hepatic injury Arcidiacono, D.
 2011
 43 S2 p. S99-
1 p.
 artikel
31 F-13 Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease Lisotti, A.
 2011
 43 S2 p. S96-
1 p.
 artikel
32 F-7 Insulin resistance does not affect sustained virologic response in patients with chronic hepatitis C without cirrhosis treated with peg-interferon alfa 2a and ribavirin Chessa, L.
 2011
 43 S2 p. S94-
1 p.
 artikel
33 F-12 Isolation and evaluation of human hepatocytes for cell-based therapy Gramignoli, R.
 2011
 43 S2 p. S96-
1 p.
 artikel
34 F-39 Is the primary immunosuppressive drug playing a role on the response to antiviral treatment for post-transplant HCV recurrence? Vero, V.
 2011
 43 S2 p. S104-
1 p.
 artikel
35 F-21 Liver collagen proportionate area correlates with esophageal varices and SVR in patients with compensated HCV cirrhosis Calvaruso, V.
 2011
 43 S2 p. S98-S99
2 p.
 artikel
36 F-40 Liver expression of IFNa/β direct target genes and treatment outcomes in HCV infection Testoni, B.
 2011
 43 S2 p. S105-
1 p.
 artikel
37 F-23 Liver related events and survival in patients with compensated HCV cirrhosis: The role of sustained virological response to PEG-IFN based therapy and portal hypertension Calvaruso, V.
 2011
 43 S2 p. S99-
1 p.
 artikel
38 F-34 Maintained long-term suppression of HBV replication in NUC-naïve patients with chronic hepatitis B treated with ETV monotherapy in field practice: The Italian multicenter experience Lampertico, P.
 2011
 43 S2 p. S102-S103
2 p.
 artikel
39 F-37 Management of extra hepatic portal vein obstruction in children Alberti, D.
 2011
 43 S2 p. S104-
1 p.
 artikel
40 F-35 Nucleos(t)ide analogues can be safely discontinued in chronic hepatitis B patients achieving HBsAg seroclearance Vezali, E.
 2011
 43 S2 p. S103-
1 p.
 artikel
41 F-42 OptiB Italian multicenter prospective study on tenofovir in suboptimal responders to ADV or ADV/LAM treatment: 96 weeks results on efficacy and tolerance Levrero, M.
 2011
 43 S2 p. S105-S106
2 p.
 artikel
42 F-2 Pattern of drug-induced liver injury: The impact of amoxicillin-clavulanate on clinical course Licata, A.
 2011
 43 S2 p. S93-
1 p.
 artikel
43 F-15 Pre-S HBV mutants do not affect HBsAG serum levels in HBeAg negative genotype D carriers, but are associated with liver disease stage and older age Stabile, A.
 2011
 43 S2 p. S97-
1 p.
 artikel
44 F-29 Reliability of serum creatinine in assessing renal function is reduced in patients with cirrhosis as compared with patients with organic renal disease Garcovich, M.
 2011
 43 S2 p. S101-
1 p.
 artikel
45 F-9 Serum SCCA-IgM as a predictor of hepatocellular carcinoma (HCC) in patients with liver cirrhosis Buccione, D.
 2011
 43 S2 p. S95-
1 p.
 artikel
46 F-22 Spleen stiffness measurement as a non-invasive predictor of esophageal varices in cirrhotic patients Colecchia, A.
 2011
 43 S2 p. S99-
1 p.
 artikel
47 F-28 Systematic error in MELD calculation by using serum creatinine measurement in cirrhosis Tsochatzis, E.
 2011
 43 S2 p. S100-S101
2 p.
 artikel
48 F-47 The adipokine chemerin as a novel factor regulating the fibrogenic phenotype of human hepatic stellate cells Galastri, S.
 2011
 43 S2 p. S107-
1 p.
 artikel
49 F-31 The persistence of HCV replication is associated with an increased mortality rate in HCV recurrent transplant patients: Results from the AISF-RECOLT-C group Rendina, M.
 2011
 43 S2 p. S101-S102
2 p.
 artikel
50 F-44 Treatment and productivity costs of chronic hepatic diseases Scalone, L.
 2011
 43 S2 p. S106-
1 p.
 artikel
51 F-16 Videocapsule endoscopy in portal hypertension: Seek till you find Pentassuglio, I.
 2011
 43 S2 p. S97-
1 p.
 artikel
52 OC-15 Accelerated chemically-induced liver fibrosis in hemojuvelin knockout mice mediated by early induction of profibrogenic cytokines Sebastiani, G.
 2011
 43 S2 p. S69-S70
2 p.
 artikel
53 OC-30 Adrenal dysfunction in nonseptic cirrhotic patients with ascites: Impact on survival Risso, A.
 2011
 43 S2 p. S74-S75
2 p.
 artikel
54 OC-13 ADVANCE study: Final results of the phase III trial with telaprevir in combination with PEG-IFN and RBV in treatment-naïve genotype 1 HCV Rizzetto, M.
 2011
 43 S2 p. S69-
1 p.
 artikel
55 OC-8 Analysis and characterization of HBV DNA integration in patients with occult HBV infection and hepatocellular carcinoma Saitta, C.
 2011
 43 S2 p. S67-
1 p.
 artikel
56 OC-7 A SVR to post-LT antiviral treatment improves long-term survival in patients with genotype 1 HCV recurrence: An “AISF RECOLT-C” Group Study Ponziani, F.R.
 2011
 43 S2 p. S67-
1 p.
 artikel
57 OC-26 Carvedilol compared to propranolol for portal hypertension in cirrhosis Sinagra, E.
 2011
 43 S2 p. S73-
1 p.
 artikel
58 OC-5 Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells Di Maira, G.
 2011
 43 S2 p. S66-
1 p.
 artikel
59 OC-27 Diagnostic accuracy of different patterns of contrast enhanced ultrasound in characterization of new nodules in liver cirrhosis with and without history of previous hepatocellular carcinoma Leoni, S.
 2011
 43 S2 p. S73-S74
2 p.
 artikel
60 OC-10 Effect of low molecular weight heparin (LMWH) on thrombin generation in cirrhotic patients Rodriguez, K.I.
 2011
 43 S2 p. S68-
1 p.
 artikel
61 OC-33 Evaluation of intestinal barrier function and histologic aspects “in vivo” and its normalization after β-blocker treatment in patients with cirrhosis and portal hypertension Nadal, E.
 2011
 43 S2 p. S75-
1 p.
 artikel
62 OC-2 Genetic variation in IL28B polymorphism may predict HBsAg clearance in genotype D, HBeAg negative patients treated with interferon alfa Lampertico, P.
 2011
 43 S2 p. S65-
1 p.
 artikel
63 OC-17 HCV burden in Europe: Impact of national treatment practices on future HCV-related morbidity and mortality through a modeling approach Stroffolini, T.
 2011
 43 S2 p. S70-
1 p.
 artikel
64 OC-34 HCV replication in patients with onco-haematological diseases Coppola, N.
 2011
 43 S2 p. S76-
1 p.
 artikel
65 OC-32 Healthy ranges for serum alanine aminotransferase concentration. It's time for a new update? Prati, D.
 2011
 43 S2 p. S75-
1 p.
 artikel
66 OC-35 Hypothalamus-pituitary dysfunction accounts for adrenal insufficiency in cirrhosis Fede, G.
 2011
 43 S2 p. S76-
1 p.
 artikel
67 OC-20 IL28B SNPs (rs8099917 and rs8099860) are associated with spontaneous HCV clearance, progression of fibrosis and response to IFN in Thalassemia Major (TM) patients Di Marco, V.
 2011
 43 S2 p. S71-S72
2 p.
 artikel
68 OC-16 Interaction between the PNPLA3 I148M mutation and body weight in determining steatosis and the progression to cirrhosis in hereditary hemochromatosis Maggioni, P.
 2011
 43 S2 p. S70-
1 p.
 artikel
69 OC-18 Liver stiffness measurement as non-invasive tool for the assessment of portal hypertension in cirrhotic patients De Filippi, F.
 2011
 43 S2 p. S71-
1 p.
 artikel
70 OC-3 MicroRNA-519d is up-regulated in hepatocellular carcinoma and sensitizes HCC cells to Doxorubicin treatment by targeting CDKN1A/p21 Fornari, F.
 2011
 43 S2 p. S66-
1 p.
 artikel
71 OC-14 miR-224 is a direct target of HBx and modulates HBV replication Scisciani, C.
 2011
 43 S2 p. S69-
1 p.
 artikel
72 OC-19 Modelling HCV kinetics by IL28B genotype is a new accurate tool for individual treatment management Colombatto, P.
 2011
 43 S2 p. S71-
1 p.
 artikel
73 OC-4 Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumor? Turato, C.
 2011
 43 S2 p. S66-
1 p.
 artikel
74 OC-12 Pegylated interferon-alpha potently augments NK cell antiviral effector function in chronic hepatitis B Micco, L.
 2011
 43 S2 p. S68-S69
2 p.
 artikel
75 OC-23 PNPLA3 sequence variant (RS738409) confers susceptibility to HCV related cirrhosis in Europeans Corradini, S. Ginanni
 2011
 43 S2 p. S72-
1 p.
 artikel
76 OC-1 Prospective Italian multicenter field-practice study with sorafenib for advanced hepatocellular carcinoma Iavarone, M.
 2011
 43 S2 p. S65-
1 p.
 artikel
77 OC-28 Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma: A randomized controlled trial Di Costanzo, G.G.
 2011
 43 S2 p. S74-
1 p.
 artikel
78 OC-31 Recipient IL-28B rs12979860 C>T polymorphism predicts acute cellular rejection in liver transplanted patients Bitetto, D.
 2011
 43 S2 p. S75-
1 p.
 artikel
79 OC-11 STAT1 and STAT2 transcription factors expression is upregulated in HBV replicating cells by distinct mechanisms Belloni, L.
 2011
 43 S2 p. S68-
1 p.
 artikel
80 OC-21 Study of HDV interference on HBV replication in human hepatoma cell lines Raffa, G.
 2011
 43 S2 p. S72-
1 p.
 artikel
81 OC-25 Survival and prognosis of hepatorenal syndrome type-1 in the era of vasoconstrictor therapy Cazzaniga, M.
 2011
 43 S2 p. S73-
1 p.
 artikel
82 OC-29 The allocation policy of liver grafts from HBcAb positive donors needs to be improved: Evidence from the Liver-Match cohort study Marianelli, T.
 2011
 43 S2 p. S74-
1 p.
 artikel
83 OC-24 The best matching for HCV genotype 1 liver transplant recipients is predicted by HCV1-STAR. A study from “AISF RECOLT-C” database Ponziani, F.R.
 2011
 43 S2 p. S73-
1 p.
 artikel
84 OC-9 The presence of hepatitis C virus deletion mutants in chronic hepatitis C patients and their role during PEG-IFN/ribavirin therapy Donnici, L.
 2011
 43 S2 p. S68-
1 p.
 artikel
85 OC-22 Vitamin A deficiency negatively affects the response to antiviral treatment in patients with chronic hepatitis C Bitetto, D.
 2011
 43 S2 p. S72-
1 p.
 artikel
86 OC-6 Vitamin D serum level and IL28B rs12979860 polymorphism are related to rapid virological response to IFN-based therapy in genotype 1 chronic hepatitis C Petta, S.
 2011
 43 S2 p. S67-
1 p.
 artikel
87 T-11 Adiponectin in nonalcoholic fatty liver disease: Correlation with liver damage and PNPLA3 genotype Rametta, R.
 2011
 43 S2 p. S80-
1 p.
 artikel
88 T-28 A metabolic switch in rat liver: Correlation between temperature and hypoxia-inducible factor-1-alpha expression Ferrigno, A.
 2011
 43 S2 p. S85-S86
2 p.
 artikel
89 T-3 A review of late acute rejection in the era of tacrolimus therapy; a study of its natural history, incidence, risk factors and graft survival Thurairajah, P.
 2011
 43 S2 p. S77-
1 p.
 artikel
90 T-42 A sustained virological response to interferon prevents insulin resistance in chronic hepatitis C patients Prati, G.M.
 2011
 43 S2 p. S90-
1 p.
 artikel
91 T-4 A 20-years survey by ITA.LI.CA on hepatocellular carcinoma (HCC) in HCV-related cirrhosis Cazzagon, N.
 2011
 43 S2 p. S78-
1 p.
 artikel
92 T-39 Biological downstaging of intermediate hepatocellular carcinoma in patients treated with sorafenib Vitale, A.
 2011
 43 S2 p. S89-
1 p.
 artikel
93 T-30 Cognitive profiles in patients with cirrhosis and long-term liver transplant recipients Giovagnoli, M.
 2011
 43 S2 p. S86-
1 p.
 artikel
94 T-37 Distribution of the IL28B rs12979860 polymorphism and its influence on sustained virological response rates in the MIST trial Aghemo, A.
 2011
 43 S2 p. S88-
1 p.
 artikel
95 T-24 Donor-related characteristics as predictors of sustained virologic response to antiviral therapy in recurrent hepatitis C after liver transplantation Iemmolo, R.M.
 2011
 43 S2 p. S84-
1 p.
 artikel
96 T-29 Early NK cell activation predicts successful treatment outcome in chronic HCV infection Oliviero, B.
 2011
 43 S2 p. S86-
1 p.
 artikel
97 T-12 Echocardiographic epicardial fat thickness in non alcoholic fatty liver disease: A possible marker of metabolic syndrome and early vascular damage Lombardi, R.
 2011
 43 S2 p. S80-S81
2 p.
 artikel
98 T-22 Effect of dietary intervention and weight loss on circulating and hepatic expression of fibroblast growth factor-21 in non alcoholic steatohepatitis Donnini, D.
 2011
 43 S2 p. S83-
1 p.
 artikel
99 T-10 Effect of prevalence of fibrosis stages on the performance of non-invasive fibrosis biomarkers in chronic liver diseases (CLDs): Results of a large-scale, international study Sebastiani, G.
 2011
 43 S2 p. S80-
1 p.
 artikel
100 T-8 Epidermal growth factor rs4444903 G/G genotype in chronic hepatitis C: Relationship with a worse disease and a more rapid fibrotic evolution Bitetto, D.
 2011
 43 S2 p. S79-
1 p.
 artikel
101 T-46 Erythropoietin administration seems to improve the decrease in platelet count observed during pegylated interferon and ribavirin treatment of patients with hepatitis C virus-related cirrhosis Giannini, E.G.
 2011
 43 S2 p. S91-
1 p.
 artikel
102 T-36 Fibrosis progression in patients with chronic hepatitis C is not influenced by IL28B polymorphisms Aghemo, A.
 2011
 43 S2 p. S88-
1 p.
 artikel
103 T-16 Follow up of esophageal varices at 3 vs 6 months after eradication by endoscopic banding in cirrhotic patients. A prospective randomized trial Ferruzzi, G.
 2011
 43 S2 p. S81-S82
2 p.
 artikel
104 T-19 Higher thyroid-stimulating hormone serum level is related to severe fibrosis in genotype 1 chronic hepatitis C patients with normal thyroid function Petta, S.
 2011
 43 S2 p. S82-S83
2 p.
 artikel
105 T-47 High prevalence of occult hepatitis C virus infection in non alcholic steatohepatitis and cryptogenetic liver diseases Granieri, C.
 2011
 43 S2 p. S91-S92
2 p.
 artikel
106 T-44 Impact of antiviral therapy on fibrosis progression due to HCV recurrence after liver transplantation: Results from the AISF RECOLT-C study group De Martin, E.
 2011
 43 S2 p. S90-S91
2 p.
 artikel
107 T-17 Impact of Gadoxetic acid (Gd-EOB-DTPA)-enhanced MR on the non-invasive diagnosis of small hepatocellular carcinoma Galassi, M.
 2011
 43 S2 p. S82-
1 p.
 artikel
108 T-25 Impact of insulin resistance on antiviral efficacy of telaprevir-based regimen in treatment-naïve genotype 1 HCV: Results from C208 sub-analysis Carosi, G.
 2011
 43 S2 p. S84-
1 p.
 artikel
109 T-45 Improved diagnostic accuracy for HCC using a combination of IgM-linked biomarkers Biasiolo, A.
 2011
 43 S2 p. S91-
1 p.
 artikel
110 T-35 In CHC patients aged =50 years ribavirin-induced anemia depends on renal function Borroni, G.
 2011
 43 S2 p. S88-
1 p.
 artikel
111 T-49 Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: Taking up a challenge for the hepatologist Lorenzini, S.
 2011
 43 S2 p. S92-
1 p.
 artikel
112 T-48 Increasing ribavirin doses improves the sustained virological response in HCV patients not responding to pegylated interferon and ribavirin Conti, F.
 2011
 43 S2 p. S92-
1 p.
 artikel
113 T-34 Interleukin-28B polymorphisms, IP-10, viral load and age predict the outcome of therapy in genotype 1 hepatitis C virus under real-life conditions Fattovich, G.
 2011
 43 S2 p. S87-S88
2 p.
 artikel
114 T-9 Interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases Fornasiere, E.
 2011
 43 S2 p. S79-
1 p.
 artikel
115 T-7 Intraocular complications during antiviral therapy for hepatitis C are common and more frequent in patients with hypertension and/or diabetes: Results of a prospective, longitudinal study Sebastiani, G.
 2011
 43 S2 p. S79-
1 p.
 artikel
116 T-18 Liver follicular helper T-cells in chronic hepatitis C Tripodo, C.
 2011
 43 S2 p. S82-
1 p.
 artikel
117 T-33 Liver steatosis in old subjects could be a predictor of possible cardiac abnormalities Zappoli, P.
 2011
 43 S2 p. S87-
1 p.
 artikel
118 T-26 Long-term FU of patients with CHC treated with telaprevir in combination with PEG-IFN alfa-2a and RBV: Interim analysis of the EXTEND study Alberti, A.
 2011
 43 S2 p. S85-
1 p.
 artikel
119 T-31 Nonalcoholic fatty liver disease and aging. Clinical course and cardiovascular risk Corvalli, G.
 2011
 43 S2 p. S86-
1 p.
 artikel
120 T-5 Oncostatin M, overexpressed in hepatocellular carcinoma, up-regulates SERPIN-B3 expression in hepatic cancer cells Cannito, S.
 2011
 43 S2 p. S78-
1 p.
 artikel
121 T-6 Oncostatin M stimulates chemotaxis of human hepatic profibrogenic cells Busletta, C.
 2011
 43 S2 p. S78-
1 p.
 artikel
122 T-38 PEG-IFN for hepatitis C in clinical practice: Results of the retrospective phase of the AIFA study Rosina, F.
 2011
 43 S2 p. S89-
1 p.
 artikel
123 T-15 PNPLA3 rs734809 C/G polymorphism in liver cirrhosis: Relationship with the etiology of liver disease and HCC occurrence Bitetto, D.
 2011
 43 S2 p. S81-
1 p.
 artikel
124 T-23 Poor adherence to pegylated interferon and ribavirin is a major concern in the treatment of hepatitis C after liver transplantation: Evidence from the AISF RECOLT-C study group Di Paolo, D.
 2011
 43 S2 p. S84-
1 p.
 artikel
125 T-21 Portal vein thrombosis affects prognosis of cirrhotic patients with previous variceal haemorrhage Amitrano, L.
 2011
 43 S2 p. S83-
1 p.
 artikel
126 T-32 Positive cardiac inotropic effect of albumin infusion in rats with cirrhosis and ascites: Molecular mechanisms Bortoluzzi, A.
 2011
 43 S2 p. S87-
1 p.
 artikel
127 T-1 Preliminary clinical results of thermal ablation of primary and metastatic tumor lesions with a new percutaneous microwaves device Poggi, G.
 2011
 43 S2 p. S77-
1 p.
 artikel
128 T-13 Protective effect of coffee on oxidative DNA damage in patients with HCV-chronic hepatitis Piciocchi, M.
 2011
 43 S2 p. S81-
1 p.
 artikel
129 T-40 Rebleeding does not affect prognosis of cirrhotic patients with advanced hepatocellular carcinoma Amitrano, L.
 2011
 43 S2 p. S89-
1 p.
 artikel
130 T-41 Sorafenib for the treatment of advanced hepatocellular carcinoma: Effectiveness and impact of adverse effects in daily clinical practice Tortora, R.
 2011
 43 S2 p. S89-S90
2 p.
 artikel
131 T-27 The antifibrotic effect of sorafenib is due to decreased HSCs activation mediated by angiogenesis blockage De Minicis, S.
 2011
 43 S2 p. S85-
1 p.
 artikel
132 T-2 The evolving clinical scenario of hepatocellular carcinoma over the last 20 years in Italy Santi, V.
 2011
 43 S2 p. S77-
1 p.
 artikel
133 T-14 The outcome of pregnancy in patients with primary sclerosing cholangitis Antoniazzi, S.
 2011
 43 S2 p. S81-
1 p.
 artikel
134 T-43 Treatment of the “uncommon” HCV genotype 4 infection recurrence after liver transplantation. Data from AISF RECOLT-C group Ponziani, F.R.
 2011
 43 S2 p. S90-
1 p.
 artikel
135 T-20 Visceral adiposity index, expression of adipose dysfunction, is associated with significant fibrosis in patients with non-alcoholic fatty liver disease Petta, S.
 2011
 43 S2 p. S83-
1 p.
 artikel
                             135 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland